Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Fallopian Tube Neoplasms × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 2 Esophageal Neoplasms 2 Squamous-Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Paclitaxel 16 Carboplatin 14 Bevacizumab 5 Taxes 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 pembrolizumab 2 oregovomab 2 niraparib 2 fluzoparib 2 Topotecan 2 ST 1481 2 Neoadjuvant Therapy 2 Methods 2 Immunohistochemistry 2 Ifosfamide 2 Gene Expression Profiling 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Cytoreduction Surgical Procedures 2 Amplified Fragment Length Polymorphism Analysis 2 rucaparib 1 paclitaxel poliglumex 1 olaparib 1 navicixizumab 1 mirvetuximab soravtansine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡